These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 20643396

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Assessment of optic nerve cup-to-disk ratio changes in patients receiving multiple intravitreal injections of antivascular endothelial growth factor agents.
    Seth RK, Salim S, Shields MB, Adelman RA.
    Retina; 2009; 29(7):956-9. PubMed ID: 19584654
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The long-term effect of intravitreal ranibizumab on retinal nerve fiber layer thickness in exudative age-related macular degeneration.
    Parlak M, Oner FH, Saatci AO.
    Int Ophthalmol; 2015 Aug; 35(4):473-80. PubMed ID: 25059401
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Retinal nerve fiber layer thickness changes in patients with age-related macular degeneration treated with intravitreal ranibizumab.
    Martinez-de-la-Casa JM, Ruiz-Calvo A, Saenz-Frances F, Reche-Frutos J, Calvo-Gonzalez C, Donate-Lopez J, Garcia-Feijoo J.
    Invest Ophthalmol Vis Sci; 2012 Sep 14; 53(10):6214-8. PubMed ID: 22915037
    [Abstract] [Full Text] [Related]

  • 32. Local and systemic complications after intravitreal administration of anti-vascular endothelial growth factor agents in the treatment of different ocular diseases: a five-year retrospective study.
    Nuzzi R, Tridico F.
    Semin Ophthalmol; 2015 Mar 14; 30(2):129-35. PubMed ID: 24171832
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.
    Tseng JJ, Vance SK, Della Torre KE, Mendonca LS, Cooney MJ, Klancnik JM, Sorenson JA, Freund KB.
    J Glaucoma; 2012 Mar 14; 21(4):241-7. PubMed ID: 21423038
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Intravitreal triamcinolone, bevacizumab and pegaptanib for occult choroidal neovascularization.
    Forte R, Cennamo G, Finelli M, Cesarano I, D'Amico G, De Crecchio G, Cennamo G.
    Acta Ophthalmol; 2010 Dec 14; 88(8):e305-10. PubMed ID: 20946332
    [Abstract] [Full Text] [Related]

  • 38. Changes in Retinal Nerve Fiber Layer Thickness after Multiple Injections of Novel VEGF Decoy Receptor Conbercept for Various Retinal Diseases.
    Zhang Z, Yang X, Jin H, Qu Y, Zhang Y, Liu K, Xu X.
    Sci Rep; 2016 Dec 06; 6():38326. PubMed ID: 27922068
    [Abstract] [Full Text] [Related]

  • 39. Impact of intravitreal ranibizumab, aflibercept and bevacizumab on retinal ganglion cell and nerve fibre layer thickness in Neovascular age-related macular degeneration.
    Abu Dail Y, Seitz B, Sideroudi H, Abdin AD.
    Acta Ophthalmol; 2023 May 06; 101(3):330-341. PubMed ID: 36345883
    [Abstract] [Full Text] [Related]

  • 40. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.
    Retina; 2008 Oct 06; 28(8):1053-60. PubMed ID: 18779710
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.